Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05895_nanopub.RA5_jBr7ojWNLGbqnWCkZXQfiNdn3Pf5lGvj9aFCpyOEI#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05895 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05895 label "HGS-TR2J [drugbank:DB05895]" assertion.
- drugbank:DB05895 seeAlso DB05895 assertion.
- drugbank:DB05895 description "HGS-TR2J is a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies. It is developed by Human Genome Sciences, Inc and is under Phase I of clinical trial." assertion.
- drugbank:DB05895 identifier "drugbank:DB05895" assertion.
- drugbank:DB05895 title "HGS-TR2J" assertion.
- drugbank:DB05895 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05895 drugbank_vocabulary:drugbank-id "DB05895" assertion.
- drugbank:DB05895 bio2rdf_vocabulary:x-identifiers.org DB05895 assertion.
- drugbank:DB05895 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05895" assertion.
- drugbank:DB05895 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05895 bio2rdf_vocabulary:identifier "DB05895" assertion.